USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Solasta Bio Limited

USPTO PatentsView assignee record — 8 granted patents across 3 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01P (BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS).

8
Total patents granted
3
CPC technology areas
10.1
Avg claims per patent
5-year filing velocity

Portfolio overview

Solasta Bio Limited has been granted 8 US utility patents between 2024 and 2025, placing Solasta Bio Limited at rank #33,426 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.1 claims per patent with primary concentration in A01P (BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS). As a Foreign Corporation, Solasta Bio Limited is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 26.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Solasta Bio Limited's 10.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Solasta Bio Limited against peers pursuing similar technology classes.

How does Solasta compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Solasta holds 8 patents — placing it at rank #33,426 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2024–2025

02468 20242025 7
USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table
Solasta Bio Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2024 1 12.5%
2025 7 87.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple

Where it ranks

Overall rank by patents

#33,426

Across all tracked assignees

Innovation Score

26.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Solasta Bio Limited hold?
Solasta Bio Limited holds 8 US granted patents filed between 2024 and 2025, spanning 3 technology areas.
What is Solasta Bio Limited's Innovation Score?
Solasta Bio Limited has an Innovation Score of 26.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Solasta Bio Limited focus on?
Solasta Bio Limited's top technology area is A01P (BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS) with 8 patents. The company has filed patents in 3 CPC subclasses total.
Is Solasta Bio Limited's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Solasta Bio Limited.
What does claim depth mean for Solasta Bio Limited's patents?
Solasta Bio Limited's patents average 10.1 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Solasta Bio Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope